Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-pentixather vs 68Ga-pentixafor PET/CT in Multiple Myeloma
NCT05364177Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2021
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Phase 1, open-label trial of 68ga-pentixather in multiple myeloma (MM), sponsored by Peking Union Medical College Hospital. Primary endpoints: Metabolic parameter at 2 years, PET-positive diffuse bone marrow involvement at 2 years and 1 more. Status: unknown.
02
Drugs
68ga-pentixather
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT05364177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05364177.